Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Jul 2026 for Entera Bio Ltd.. Read the official filing
Filing timeline
BuySaleMiranda Jayne Toledano
Insider track record
Disclosed buys
6
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+11.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Miranda Jayne Toledano: trading record in brief
Miranda Jayne Toledano is a declared insider at 4 companies (board member); the most frequent names are Entera Bio Ltd., Journey Medical Corp and Compass Therapeutics, Inc. Between 25 June 2021 and 14 July 2026, the trades on record add up to 17 filings.
On the market, this insider has only ever bought: 6 purchases, €111k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 10 share grants.
A typical purchase (the median) is worth €17k. On 4 out of 6 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 16 July 2026, reports a share grant in Entera Bio Ltd. The latest purchase dates back some time: it was published 292 days ago, on 30 December 2025. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Miranda Jayne Toledano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
347,567 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-26-003508:0
72,993 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-26-003508:1
11,000 shares@ US$1.810216.5% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-25-004125:0
Canonical exit: 29 Mar 2026 (T+90)
20,000 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-075266:0
136,842 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-25-002414:0
7,173 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-066240:0
124,121 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-24-002391:0
9,728 shares0Common Stock, $0.0001 par valueSEC:0001104659-24-078970:0
23,952 shares@ US$0.7115.1% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-23-003971:0
Canonical exit: 21 Mar 2024 (T+90)
27,472 shares0Common Stock, par value $0.0001 per shareSEC:0001104659-23-083831:0
30,000 shares@ US$1.0127.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-23-001348:0
Canonical exit: 3 Jul 2023 (T+90)
50,000 shares@ US$0.531725.5% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-003988:0
Canonical exit: 9 Feb 2023 (T+90)
14,245 shares0Common Stock, par value $0.0001 per shareSEC:0001104659-22-082287:0
30,000 shares0COMMON STOCKSEC:0001104659-22-042282:0
6,800 shares@ US$2.789916.1% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000165:0
Canonical exit: 14 Apr 2022 (T+90)
1,819 shares@ US$5.49100.0% of flowCommon StockSEC:0001104659-22-000437:0
Canonical exit: 27 Mar 2022 (T+90)
1,791,549 sharesCommon Stock, $.0001 Par ValueSEC:0001686530-21-000006:0
17 of 17 declarations
